Properties of p53 mutations detected in primary and secondary cervical cancers suggest mechanisms of metastasis and involvement of environmental carcinogens.

por Crook, T, Vousden, K H
Publicado 1992

A point mutational analysis of human papillomavirus type 16 E7 protein.

por Edmonds, C, Vousden, K H
Publicado 1989

Activation and activities of the p53 tumour suppressor protein

por Bálint, É, Vousden, K H
Publicado 2001

Perturbation of the p53 response by human papillomavirus type 16 E7.

por Hickman, E S, Bates, S, Vousden, K H
Publicado 1997

Proteolytic cleavage of human p53 by calpain: a potential regulator of protein stability.

por Kubbutat, M H, Vousden, K H
Publicado 1997

Modulation of immortalizing properties of human papillomavirus type 16 E7 by p53 expression.

por Crook, T, Fisher, C, Vousden, K H
Publicado 1991

Three different activated ras genes in mouse tumours; evidence for oncogene activation during progression of a mouse lymphoma.

por Vousden, K H, Marshall, C J
Publicado 1984

Differential activation of target cellular promoters by p53 mutants with impaired apoptotic function.

por Ludwig, R L, Bates, S, Vousden, K H
Publicado 1996

Human papillomavirus detection by hybrid capture and its possible clinical use.

por Farthing, A, Masterson, P, Mason, W P, Vousden, K H
Publicado 1994

Mutational analysis of bovine papillomavirus E6 gene.

por Vousden, K H, Androphy, E J, Schiller, J T, Lowy, D R
Publicado 1989

E5 open reading frame of bovine papillomavirus type 1 encodes a transforming gene.

por Schiller, J T, Vass, W C, Vousden, K H, Lowy, D R
Publicado 1986

Absence of HPV 16 and 18 DNA in breast cancer.

por Wrede, D., Luqmani, Y. A., Coombes, R. C., Vousden, K. H.
Publicado 1992

p53- and p73-independent activation of TIGAR expression in vivo

por Lee, P, Hock, A K, Vousden, K H, Cheung, E C
Publicado en Cell Death Dis (2015)

Mutations activating human c-Ha-ras1 protooncogene (HRAS1) induced by chemical carcinogens and depurination.

por Vousden, K H, Bos, J L, Marshall, C J, Phillips, D H
Publicado 1986

p53 is frequently mutated in Burkitt's lymphoma cell lines.

por Farrell, P J, Allan, G J, Shanahan, F, Vousden, K H, Crook, T
Publicado 1991

HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes.

por Hawley-Nelson, P, Vousden, K H, Hubbert, N L, Lowy, D R, Schiller, J T
Publicado 1989

Specific loss of apoptotic but not cell-cycle arrest function in a human tumor derived p53 mutant.

por Rowan, S, Ludwig, R L, Haupt, Y, Bates, S, Lu, X, Oren, M, Vousden, K H
Publicado 1996

The region of the HPV E7 oncoprotein homologous to adenovirus E1a and Sv40 large T antigen contains separate domains for Rb binding and casein kinase II phosphorylation.

por Barbosa, M S, Edmonds, C, Fisher, C, Schiller, J T, Lowy, D R, Vousden, K H
Publicado 1990

HPV16 E7 oncoprotein deregulates B-myb expression: correlation with targeting of p107/E2F complexes.

por Lam, E W, Morris, J D, Davies, R, Crook, T, Watson, R J, Vousden, K H
Publicado 1994

Human papillomavirus E6 proteins bind p53 in vivo and abrogate p53-mediated repression of transcription.

por Lechner, M S, Mack, D H, Finicle, A B, Crook, T, Vousden, K H, Laimins, L A
Publicado 1992